Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 31, 2021
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
Jason Mills Maintained (ANGO) at Hold with Increased Target to $24 on, Mar 31st, 2021
Jason Mills of Canaccord Genuity, Maintained "AngioDynamics, Inc." (ANGO) at Hold with Increased Target from $18 to $24 on, Mar 31st, 2021.
Jason has made no other calls on ANGO in the last 4 months.
There is 1 other peer that has a rating on ANGO. Out of the 1 peers that are also analyzing ANGO, 0 agree with Jason's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jason
- Jayson Bedford of "Raymond James" Maintained at Strong Buy with Increased Target to $24 on, Friday, January 8th, 2021
